UMC 0256 UMEDIC GROUP BERHAD | A Growing Company (Q3FY2023)
With the advancement of global medical technology and increased cross-border collaborations, the research, development, and manufacturing of high-end medical devices have been continuously improving. The application of new materials, sensors, artificial intelligence, and machine learning technologies has greatly facilitated the innovation and progress of high-end medical devices.
Just a few days ago, UMedic Group Berhad (UMC, 0256), a high-end medical equipment provider, released an impressive performance report, leading to a surge in the company's stock price.
Let's briefly comprehend this company’s background. Headquartered in Penang, UMC was established in 2002 and went public on the ACE Market in July 2022. The company is primarily engaged in the manufacturing, marketing, and after-sales services of various medical devices. It is worth mentioning that the company holds distribution rights for multiple international medical equipment companies, including GE Healthcare, Mindray, and Philips. In addition, UMC develops and manufactures its own brand of medical products, namely the HydroX series of prefilled humidifiers and the AirdroX series of asthma spacers.
To date, UMC has provided professional medical equipment and related services to thousands of customers, including public and private hospitals, healthcare service providers, hotels, airports, factories, and more, spanning over 30 countries worldwide. According to the 2022 annual report, UMC's customers are primarily from Malaysia, accounting for approximately 80.09% of the total revenue for the 2022 financial year. The Asia-Pacific region, including South Korea, India, Indonesia, Myanmar, the Philippines, Thailand, and Brunei, accounted for approximately 10.29% of the revenue. The remaining markets include Europe (6.84%), the United States (1.78%), the Middle East (0.47%), Oceania (0.35%), and Africa (0.18%).
Now, let's discuss UMC's latest performance in Q3FY2023.
Revenue Comparison (YoY +48.22%, QoQ -23.40%)
For the third quarter ending on April 30, 2023, the company achieved revenue of approximately RM9.59 million, an increase of approximately RM3.12 million or 48.22% compared to the same period last year, which was around RM6.47 million. This growth was primarily due to increased demand for medical devices from both public and private hospitals, as well as healthcare service providers. Additionally, the management stated that the revenue growth was also driven by increased sales of the company's HydroX and AirdroX products.
However, compared to the immediate preceding quarter, the company's revenue decreased by approximately RM2.93 million or 23.40%. This was due to a decline in sales of medical devices.
Net Profit Comparison (YoY +58.13%, QoQ -29.89%)
Benefiting from favorable foreign exchange rates and the growth in sales of medical devices and related products, the company's net profit increased by approximately RM0.75 million or 58.13% year-on-year, reaching around RM2.04 million.
As mentioned earlier, due to the decline in medical device sales this quarter, the company's net profit decreased by approximately RM0.87 million or 29.89% compared to the immediate preceding quarter.
Outlook
This year, the Malaysian Ministry of Health received a budget allocation of approximately RM36.30 billion through Budget 2023, which is higher than the previous year's allocation of around RM32.40 billion. This indicates that the government places significant emphasis on the domestic healthcare sector, which is good news for UMC. Therefore, the management remains confident about the company's future profit growth.
So, what are your thoughts on UMC, currently trading at a price-to-earnings ratio (P/E) of approximately 36.58?
#UMC
https://xifu.my/OpinionsComment.aspx?BID=B02284008PBAB0E0
Singapore Investment
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
SingTel – Healthy core business1 day ago
-
-
-
Retire in Japan: The Complete Guide2 days ago
-
-
-
-
-
-
-
-
-
-
-
-
-
Finance Investment Movement 453 days ago
-
-
-
-
-
-
-
-
Quick Update6 days ago
-
Would you rather…6 days ago
-
-
-
Market Weekly Outlook1 week ago
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Post-BTO Sales Liquidity1 week ago
-
-
Monthly IBKR Update – Apr 20241 week ago
-
-
-
-
-
-
China’s going downhill?2 weeks ago
-
-
No new investment for retirees2 weeks ago
-
-
The Story Behind Maybank2 weeks ago
-
Mar 2024 Portfolio2 weeks ago
-
-
-
Portfolio Summary for April 20242 weeks ago
-
Portfolio (April 30, 2024)2 weeks ago
-
Summary of April 20242 weeks ago
-
Portfolio -- Apr 20242 weeks ago
-
-
-
-
-
That Restless Night…3 weeks ago
-
-
-
-
-
-
-
-
-
-
-
-
-
2024 (Portfolio Update)1 month ago
-
-
1Q 2024 Investment Strategy Update1 month ago
-
-
-
Burnt out!1 month ago
-
-
Feb 2024 Expenditure1 month ago
-
-
New Bitcoin All Time High Before Halving2 months ago
-
-
-
-
-
-
The Market Is A Scam!2 months ago
-
-
-
-
-
Options Trading Journal Jan 20243 months ago
-
-
-
-
-
End of 2023 Review4 months ago
-
-
Year 2023 DIYQuant Portfolio Performance Report4 months ago
-
Monthly Summary of November 20235 months ago
-
3 Simple Poker Strategies for Beginners5 months ago
-
Migration of website5 months ago
-
-
-
-
-
-
-
-
-
August 2023 Portfolio Updates8 months ago
-
-
-
-
Hello SP Group, I'm Back!10 months ago
-
-
-
-
A New Light1 year ago
-
-
-
-
-
-
-
Demoralized1 year ago
-
2022 Thoughts, Hello 2023!1 year ago
-
Series of Defaults for Maple Finance1 year ago
-
Takeaways from “Sea Change”1 year ago
-
-
Greed is Coming Back1 year ago
-
-
-
-
-
-
-
-
-
-
-
What is Overemployment1 year ago
-
-
-
-
-
-
-
-
-
-
-